Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BNT162b2 Protection against the Omicron Variant in Children and Adolescents
Ashley M. Price, Samantha M. Olson, Margaret M. Newhams, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 20, pp. 1899-1909
Open Access | Times Cited: 221

Showing 1-25 of 221 citing articles:

Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants
Qian Wang, Sho Iketani, Zhiteng Li, et al.
Cell (2022) Vol. 186, Iss. 2, pp. 279-286.e8
Open Access | Times Cited: 743
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Wei-Yu Chi, Yen-Der Li, Hsin‐Che Huang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 166
Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years of Age
Sharon Hui Xuan Tan, Alex R. Cook, Derrick Heng, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 6, pp. 525-532
Open Access | Times Cited: 112
Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5–11 years in Italy: a retrospective analysis of January–April, 2022
Chiara Sacco, Martina Del Manso, Alberto Mateo‐Urdiales, et al.
The Lancet (2022) Vol. 400, Iss. 10346, pp. 97-103
Open Access | Times Cited: 110
Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age
Evan J. Anderson, C. Buddy Creech, Vladimir Berthaud, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 18, pp. 1673-1687
Open Access | Times Cited: 107
Assessment of COVID-19 as the Underlying Cause of Death Among Children and Young People Aged 0 to 19 Years in the US
Seth Flaxman, Charles A. Whittaker, Elizaveta Semenova, et al.
JAMA Network Open (2023) Vol. 6, Iss. 1, pp. e2253590-e2253590
Open Access | Times Cited: 99
BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age
Chandra J. Cohen-Stavi, Ori Magen, Noam Barda, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 3, pp. 227-236
Open Access | Times Cited: 87
Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization
Daniel R. Feikin, Laith J. Abu‐Raddad, Nick Andrews, et al.
Vaccine (2022) Vol. 40, Iss. 26, pp. 3516-3527
Open Access | Times Cited: 79
Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021–March, 2022: a national, observational, test-negative, case-control study
Annabel Powell, Freja Kirsebom, Julia Stowe, et al.
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 4, pp. 435-444
Open Access | Times Cited: 73
Assessment of Efficacy and Safety of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years
Atsuyuki Watanabe, Ryoma Kani, Masao Iwagami, et al.
JAMA Pediatrics (2023) Vol. 177, Iss. 4, pp. 384-384
Open Access | Times Cited: 60
Safety and effectiveness of vaccines against COVID-19 in children aged 5–11 years: a systematic review and meta-analysis
Vanessa Piechotta, Waldemar Siemens, Iris Thielemann, et al.
The Lancet Child & Adolescent Health (2023) Vol. 7, Iss. 6, pp. 379-391
Open Access | Times Cited: 51
Vaccine Effectiveness Against Long COVID in Children
Hanieh Razzaghi, Christopher B. Forrest, Kathryn Hirabayashi, et al.
PEDIATRICS (2024) Vol. 153, Iss. 4
Closed Access | Times Cited: 24
Covid-19 Vaccine Protection among Children and Adolescents in Qatar
Hiam Chemaitelly, Sawsan AlMukdad, Houssein H. Ayoub, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 20, pp. 1865-1876
Open Access | Times Cited: 55
Effects of Vaccination and Previous Infection on Omicron Infections in Children
D. Y. Lin, Yu Gu, Yangjianchen Xu, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 12, pp. 1141-1143
Open Access | Times Cited: 48
Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case–control study
Vincent Ka Chun Yan, Eric Yuk Fai Wan, Xuxiao Ye, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2304-2314
Open Access | Times Cited: 44
Peripartum Outcomes Associated With COVID-19 Vaccination During Pregnancy
Atsuyuki Watanabe, Jun Yasuhara, Masao Iwagami, et al.
JAMA Pediatrics (2022) Vol. 176, Iss. 11, pp. 1098-1098
Open Access | Times Cited: 43
BNT162b2 mRNA Vaccination Against Coronavirus Disease 2019 is Associated With a Decreased Likelihood of Multisystem Inflammatory Syndrome in Children Aged 5–18 Years—United States, July 2021 – April 2022
Laura D. Zambrano, Margaret M. Newhams, Samantha M. Olson, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e90-e100
Open Access | Times Cited: 38
Effectiveness of SARS-CoV-2 vaccines against Omicron infection and severe events: a systematic review and meta-analysis of test-negative design studies
Shangchen Song, Zachary J. Madewell, Ming‐Jin Liu, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 29
Effectiveness of BNT162b2 and CoronaVac in children and adolescents against SARS-CoV-2 infection during Omicron BA.2 wave in Hong Kong
Daniel Leung, Jaime S. Rosa Duque, Ka Man Yip, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 23
Clinical Characteristics and Outcomes of Children With SARS-CoV-2 Infection During the Delta and Omicron Variant-Dominant Periods in Korea
Soo‐Han Choi, Jae Hong Choi, Joon Kee Lee, et al.
Journal of Korean Medical Science (2023) Vol. 38, Iss. 9
Open Access | Times Cited: 23
Effectiveness of an inactivated SARS-CoV-2 vaccine in children and adolescents: a large-scale observational study
Alejandro Jara, Eduardo A. Undurraga, Juan Carlos Flores, et al.
The Lancet Regional Health - Americas (2023) Vol. 21, pp. 100487-100487
Open Access | Times Cited: 22
Immunogenicity, effectiveness, and safety of COVID-19 vaccines among children and adolescents aged 2–18 years: an updated systematic review and meta-analysis
Peng Gao, Liangyu Kang, Jue Liu, et al.
World Journal of Pediatrics (2023) Vol. 19, Iss. 11, pp. 1041-1054
Open Access | Times Cited: 21
SARS-CoV-2 Related Antibody-Dependent Enhancement Phenomena In Vitro and In Vivo
Emi E. Nakayama, Tatsuo Shioda
Microorganisms (2023) Vol. 11, Iss. 4, pp. 1015-1015
Open Access | Times Cited: 21
A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccines
Xiao‐Feng He, Jiao Su, Yunan Ma, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35
Effectiveness of BBIBP-CorV, BNT162b2 and mRNA-1273 vaccines against hospitalisations among children and adolescents during the Omicron outbreak in Argentina: A retrospective cohort study
Soledad González, Santiago Olszevicki, Alejandra Gaiano, et al.
The Lancet Regional Health - Americas (2022) Vol. 13, pp. 100316-100316
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top